2013 European guideline for the management of balanoposthitis.
Balanoposthitis can be caused by a disparate range of conditions affecting the penile skin. This guideline concentrates on a selected group of conditions and offers recommendations on the diagnostic tests and treatment regimens needed for the effective management of balanoposthitis.
Department of Genitourinary Medicine, Cambridgeshire Community Services, Bury St Edmunds, UK sarah.edwards6@nhs.net.
S K
SK
Edwards
Department of Dermatology, University College Hospital, London, UK.
C B
CB
Bunker
Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany.
Fabian
F
Ziller
Department of Dermatology, Havenziekenhuis, Rotterdam, The Netherlands.
Willem I
WI
van der Meijden
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001446:Balanitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D019468:Disease Management; D006801:Humans; D008297:Male; D010409:Penile Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D010413:Penis / Q000382:microbiology*; D017410:Practice Guidelines as Topic; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents
Balanitis; Bowenoid papulosis; Bowen’s disease; Zoon’s; aerobic; anaerobic; balanoposthitis; candida; circinate; eczema; erythroplasia of Queyrat; lichen planus; lichen sclerosus; men; penile dermatoses; psoriasis; sexual health